Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Journal of Immunological Methods|October 17, 2020
A novel co-culture assay to assess anti-tumor CD8+ T cell cytotoxicity via luminescence and multicolor flow cytometryVerónica Olivo Pimentel, Ala Yaromina, Damiënne Marcus, et al.Cancers|April 3, 2021
Charged Particle and Conventional Radiotherapy: Current Implications as Partner for ImmunotherapyDamiënne Marcus, Relinde I Y Lieverse, Carmen Klein, et al.Cancers|June 19, 2020
Use of a Luciferase-Expressing Orthotopic Rat Brain Tumor Model to Optimize a Targeted Irradiation Strategy for Efficacy Testing with TemozolomideAlexandra M Mowday, Natasja G Lieuwes, Rianne Biemans, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 22, 2019
Evofosfamide sensitizes esophageal carcinomas to radiation without increasing normal tissue toxicityLinda Spiegelberg, Stefan J van Hoof, Rianne Biemans, et al.Molecular Oncology|May 10, 2020
Human fibronectin extra domain B as a biomarker for targeted therapy in cancerRelinde I Y Lieverse, Damiënne Marcus, Alexander M A van der Wiel, et al.Seminars in Radiation Oncology|May 9, 2020
Lymphocyte-Sparing Radiotherapy: The Rationale for Protecting Lymphocyte-rich Organs When Combining Radiotherapy With ImmunotherapyPhilippe Lambin, Relinde I Y Lieverse, Franziska Eckert, et al.The British Journal of Radiology|May 26, 2017
Combining radiotherapy with immunotherapy: the past, the present and the futureEvert J Van Limbergen, Dirk K De Ruysscher, Veronica Olivo Pimentel, et al.Journal for Immunotherapy of Cancer|March 10, 2021
Releasing the brakes of tumor immunity with anti-PD-L1 and pushing its accelerator with L19-IL2 cures poorly immunogenic tumors when combined with radiotherapyVeronica Olivo Pimentel, Damiënne Marcus, Alexander Ma van der Wiel, et al.Cancers|May 28, 2020
Hypoxia PET Imaging with [18F]-HX4-A Promising Next-Generation TracerSebastian Sanduleanu, Alexander M A van der Wiel, Relinde I Y Lieverse, et al.Nature Medicine|April 18, 2017
Marginal zone B cells control the response of follicular helper T cells to a high-cholesterol dietMeritxell Nus, Andrew P Sage, Yuning Lu, et al.Pageof 2